Eden Research (LON:EDEN) Trading 26.5% Higher – Still a Buy?

Eden Research plc (LON:EDENGet Free Report)’s stock price rose 26.5% during trading on Wednesday . The stock traded as high as GBX 3.48 ($0.05) and last traded at GBX 3.48 ($0.05). Approximately 778,726 shares were traded during mid-day trading, an increase of 16% from the average daily volume of 670,749 shares. The stock had previously closed at GBX 2.75 ($0.04).

Eden Research Price Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of £20.27 million, a PE ratio of -13.31 and a beta of 0.92. The firm has a 50 day moving average price of GBX 2.79 and a 200 day moving average price of GBX 3.43.

Eden Research (LON:EDENGet Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) EPS for the quarter. Eden Research had a negative return on equity of 11.63% and a negative net margin of 38.70%. Research analysts anticipate that Eden Research plc will post -66.0000038 earnings per share for the current year.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Sean M. Smith purchased 426,986 shares of the firm’s stock in a transaction on Tuesday, April 1st. The shares were acquired at an average cost of GBX 234 ($3.11) per share, with a total value of £999,147.24 ($1,329,714.19). Also, insider Alexander John Abrey purchased 167,947 shares of the firm’s stock in a transaction on Tuesday, March 4th. The shares were acquired at an average cost of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,705.36). Insiders own 14.02% of the company’s stock.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

See Also

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.